Medicinal chemistry – Page 69
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports
-
NewsIndian supreme court’s anger over unregulated clinical trials
Tales of collusion between drug companies and regulators leads court to criticise the government
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture
-
Business
EPA focuses on five chemicals
Risk assessments for five chemicals put out for public consultation
-
Business
Illumina investment push
$450 million deal for privately owned US firm Verinata Health, which makes chromosomal tests
-
Business
TB drug milestone for bedaquiline
First TB drug with a new mechanism of action for 40 years wins approval
-
FeatureMaking pain history
From ancient folk remedy to the wonder drug of the early industrial age and beyond. Mike Sutton traces the remarkable history of aspirin
-
Business
Return on drug R&D dropping
The pharma industry is getting less and less return on investment in R&D but trend seems to be bottoming out
-
Business
Drug R&D costs rising
Review from UK consultancy suggests ten-fold increase in per medicine R&D costs over last 30 years
-
Business
Roche and the Tamiflu data
Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening
-
OpinionFull disclosure?
The pharma industry should be more open with its trial data, says Derek Lowe
-
CareersNobel signals for new drugs
Sarah Houlton talks to a company that’s capitalising on the chemistry of communication
-
News
GSK pledge on trials transparency
Pharma giant tackles critics by announcing that it will publish all clinical trials data regardless of the result
-
Business
Bayer and Evotec team up on endometriosis
German collaboration aims to develop three drug candidates in five years
-
OpinionColour and controversy
Bob Hefford considers the spotted past and uncertain future of the chemicals that built the hair dye industry
-
NewsChinese drug makers accused of using ‘gutter oil’
Oil reclaimed from drains may have been used to make an antibiotic intermediate
-
FeatureFood with a function
Compounds normally thought of as medicines are being added to food. Elinor Hughes looks at the scientific and regulatory challenges facing these nutraceuticals.
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
OpinionProtecting patients at all costs
Suffering stagnant output, and beset by patent expiries and spiralling costs, drug discovery is in poor health. Simon Campbell prescribes a remedy
-
OpinionMonopoly money
Dean Baker says it’s time to start talking seriously about the way in which pharma is funded